(firstQuint)Tinzaparin in the Treatment of the Acute Pulmonary Embolism.

 The open-label prospective randomized clinical trial compares subcutaneous LMWH (tinzaparin) administered for 6 months versus initial treatment using subcutaneous LMWH followed by oral anticoagulants given for 6 months in patients with acute venous thrombosis.

 To evaluate the direct and indirect cost of each treatment regimen in a rural population environment.

.

 Tinzaparin in the Treatment of the Acute Pulmonary Embolism@highlight

The purpose of this study is to evaluate the feasibility of the long-term treatment of pulmonary embolism with tinzaparin compared to oral anticoagulants.

